Scientists will be able to detect cancer earlier from blood samples after advances were made in detecting microRNA molecules using gold-plated nanoparticles.
UNSW researchers have discovered a new way to detect ultralow levels of microRNA in a blood sample which could make diagnosis of cancer and other illnesses quicker and more efficient.
The research team used nanoparticles to latch on to the targeted microRNAs (miRNAs) which enabled them to be easily extracted. One of the main benefits was that it was effective even when the miRNA was in minuscule amounts in the blood sample. Previously, a much larger sample was needed to extract similar amounts.
MicroRNAs are short RNA molecules that target some messenger RNAs (genetic material used to synthesise proteins) to prevent them from coding for a specific protein. Impaired miRNA activity has been linked with the formation of cancerous tumours as well as metastasis, the spread of cancer to other parts of the body.
In the paper published today in Nature Nanotechnology, the researchers reported modifying gold-coated magnetic nanoparticles (Au@MNPs) with DNA to match the miRNA they wanted to detect.
Scientia Professor Justin Gooding said the nanoparticles are, in effect, dispersible electrodes. When circulated through the blood they capture the miRNA before a magnet is used to recapture the nanoparticles with the newly attached microRNA.
“Now we get more of the microRNA because the dispersible electrodes capture nearly everything in the sample,” Professor Gooding said.
“Because the capture is so effective, we get higher sensitivities and can detect much lower limits.
“And since we bring them back to the electrode under a magnet, our response time is much faster.”
One of the advantages of being quicker is that it will cost less.
“It could be orders of magnitude cheaper. Our method takes 30 minutes compared with almost 12 hours for quantitative polymerase chain reaction,” Professor Gooding said.
Key to the new technology is not just the ability to detect lower concentrations of miRNA but the ability to detect a broad range of concentrations.
“This is really important to determine whether the levels of different microRNAs have increased or decreased,” Professor Gooding said.
“We can do this very quickly compared with the gold-standard nucleic acid amplification methods. And we can do it in unprocessed blood.
“What this means is the technology has the potential to determine the levels of microRNA just from a finger prick test.”
Professor Gooding said he would expect the technology to be available within three years, pending regulatory approvals.
The new diagnostic technique follows on the heels of a similar advance made by another UNSW research team exploring cancer detection in the blood.
In that study, published in Nature Communications, a team of medical researchers led by Professor Chris Heeschen developed a new way to detect early-stage cancer tumour cells in the blood using a malaria protein. This method, which targeted individual cancer cells found in a blood sample, also used a magnet to retrieve all the targeted cancer cells.
Professor Gooding believes the two methods, while working on very different scales, would be very complementary as tools to diagnose cancer.
“The malaria protein technology works by detecting cancer cells, rare cells in particular. These are found in the blood also and so are also compatible with the liquid biopsy concept,” he said.
“We are detecting small molecules found in the blood which could also identify the type of cancer, while they are looking for rare cells that are responsible for the spread of cancer. The two technologies could work very well together.”
Learn more: Blood-borne cancer detection receives gold-plated boost
The Latest on: Cancer blood test
[google_news title=”” keyword=”cancer blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer blood test
- Artificial intelligence could help diagnose cancer with one spot of dried bloodon May 1, 2024 at 2:32 pm
Scientists in China have created a test using artificial intelligence that can detect cancer using one spot of dried blood.
- One-two punch treatment delivers blood cancer knockouton May 1, 2024 at 12:49 pm
A novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML), one of the most common types of blood cancers. A new study has ...
- Researchers identify biomarkers in blood to predict liver canceron May 1, 2024 at 11:19 am
Early detection has the potential to transform treatment and outcomes in cancer care, especially for cancers like liver cancer, which is typically diagnosed at a late stage with limited options for ...
- Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testson May 1, 2024 at 6:47 am
a laboratory head in WEHI's Blood Cells and Blood Cancer division, said. "It is these two drugs, working in tandem, that led to the highly effective killing of AML cancer cells in our lab-based tests, ...
- Prostate cancer survivor sheds light on common stigmason May 1, 2024 at 6:01 am
“Because symptoms often don't appear before the cancer is at a more advanced stage, we need to be much louder about prostate cancer awareness and utilizing early detection as the first line of defense ...
- This Bathroom Issue Is a Common Sign of Colon Cancer, According to a GI Docon May 1, 2024 at 3:25 am
In fact, by the time someone does flag blood in the stool, it may no longer be an "early symptom" of colon cancer. "Blood in the stool is a relatively late sign of colorectal cancer and does not ...
- Dallas’ Breakthrough Blood Test for Canceron April 30, 2024 at 7:12 pm
A North Dallas diagnostic firm may be on the verge of revolutionizing the cancer screening process. Cancer Check Labs has developed a technology that can screen 40ml of blood and detect the growth of ...
- AI tool may help detect cancer in a few minutes with a drop of bloodon April 29, 2024 at 7:57 am
An AI-powered tool may be able to detect pancreatic, gastric, or colorectal cancer with a sensitivity of 82–100% and takes just a few minutes, a new study indicates.
- New blood test shows promise in early detection of ovarian canceron April 28, 2024 at 7:28 pm
A study reveals that glycoproteins in blood could be key biomarkers for early detection and staging of epithelial ovarian cancer, potentially allowing diagnosis through a simple blood test.
- Balancing hope and reality: The promise and peril of blood-based colorectal cancer screeningon April 24, 2024 at 1:30 am
A simple blood test to detect colorectal cancer sounds amazing. But unlike colonoscopy, a blood test can't remove precancerous polyps.
via Bing News